Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Leadership
Pink Sheet
Scrip
Frustration Over English Funding Rejection For Zytiga And A Win For Ledaga
Zyntiga Decision 'Highlights Need For Innovative Pricing Models'
Jul 20 2021
•
By
Neena Brizmohun
NICE has said no to funding for Zytiga for newly diagnosed, advanced prostate cancer • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet